Skip to content
Review

Limited Evidence for Non-Invasive Brain Stimulation as a Cognitive Enhancer in Neurodevelopmental Disorders: A Multilevel Meta-Analysis of Sham-Controlled Trials.

Oct 2026 · Neuroscience and Biobehavioral Reviews · pp. 107066 · 0 citations · 109 references
Medicine

Abstract

Non-invasive brain stimulation (NIBS) is increasingly applied to ameliorate cognitive deficits in neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and intellectual disability, yet whether standardized scalp-based protocols produce reliable cognitive enhancement remains untested at scale. This study evaluates the transdiagnostic efficacy of NIBS on shared, non-core cognitive domains across NDDs, searching MEDLINE, PsycINFO, Embase, Web of Science, and the Cochrane Library from inception to January 2026. A three-level multivariate random-effects meta-analysis synthesized effect sizes while accounting for dependency among multiple outcomes contributed by the same study. From 9191 identified records (5237 after deduplication), 30 randomized sham-controlled trials yielding 178 effect sizes across seven cognitive domains were synthesized. NIBS did not significantly outperform sham for any domain: working memory (k=24; g=-0.16, 95% CI [-0.37, 0.05]), cognitive flexibility (k=11; g=-0.12 [-0.38, 0.13]), global executive function (k=8; g=-0.14 [-0.46, 0.18]), processing speed (k=8; g=-0.27 [-0.77, 0.23]), inhibitory control (k=4; g=-0.08 [-0.62, 0.46]), verbal fluency (k=5; g=-0.11 [-0.59, 0.38]), or self-monitoring/behavioral metacognition (k=4; g=0.13 [-0.60, 0.86]). The pooled cross-domain estimate reached nominal significance (g=-0.18, p=0.035) but fell below the small-effect threshold, and its wide prediction interval (95% PI [-1.01, 0.66]) spanned benefit and harm. Exploratory diagnosis-stratified analyses were likewise null in both ADHD and ASD (all p>0.10). Current unstandardized, "one-size-fits-all" NIBS protocols do not yield reliable cognitive enhancement across NDDs, exposing a translational bottleneck driven by methodological heterogeneity. Realizing NIBS therapeutic potential for cognition in NDDs will require a shift toward precision psychiatry, utilizing individualized neuro-navigation and state-dependent stimulation.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.